IMNP Stock Price and Discussion
Has Immune Pharmaceuticals Been Receiving Favorable News Coverage?
Media headlines about IMNP stock have been trending somewhat negative recently, according to InfoTrie. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks analysis of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Immune Pharmaceuticals earned a news sentiment score of -1.0 on InfoTrie’s scale.
They also assigned news analysis about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock’s share price in the immediate future. View News Stories for Immune Pharmaceuticals.
Immune Pharmaceuticals Inc (IMNP) Stock Market info
Buy or sell Immune Pharmaceuticals stock? Wall Street Stock Market & Finance report, prediction for the upcoming years: You’ll find the Immune Pharmaceuticals share forecasts, stock quote and buy/sell signals below. According to present data, Immune Pharmaceuticals’s IMNP shares and potentially it’s market environment have been in bearish cycle last 12 months (if exists). Currently, there looking to be a trend where stocks in the Other sector(s) are not very popular in this period.
For More Latest’s Audition Date and Places News
Our Ai stock analyst implies that there will be a positive trend in the future and the IMNP shares might be good for investing in making money. Since this share has a positive outlook we recommend it as a part of your portfolio. Trading in bull markets is always easier so you might want to favor these shares under the given circumstances but always read up on optimal expense strategies if you are new to investing. If you are good with personal finance and are looking to invest, you will find the Immune Pharmaceuticals on OTCQB stock exchange.
What Is Immune Pharmaceuticals’ Stock Symbol?
Immune Pharmaceuticals trades on the NASDAQ under the ticker badge “IMNP.”
How Were Immune Pharmaceuticals’ Earnings Last Quarter?
Immune Pharmaceuticals Inc (NASDAQ: IMNP) released its quarterly earnings results on Tuesday, May, 15th. The biopharmaceutical company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.05. View Immune Pharmaceuticals’ Earnings History.
What is the Immune Pharmaceuticals stock market price/share price today?
The stock price of Immune Pharmaceuticals is 0.00320 USD today.
Will Immune Pharmaceuticals stock price grow/rise/go up?
Yes. The IMNP stock price can grow up from 0.00320 USD to 2.703 USD in one year.
Is it profitable to spend in Immune Pharmaceuticals stock?
Yeah, The long-term earning potential is +84381.88% in one year.
Will IMNP stock price fall/drop?
What will Immune Pharmaceuticals stock market price be worth in five years (2024)?
The IMNP (“IMNP” ) stock price for the future will be 0.327 USD.
Will the IMNP stock price crash?
According to our analysis, this will not happen.
Will Immune Pharmaceuticals stock market price hit 1 USD price in a year?
Yes, within a year.
Will Immune Pharmaceuticals stock market price hit 5 USD price in a year?
Not within a year.
Will Immune Pharmaceuticals stock market price hit 10 USD price in a year?
Not within a year.
Here you will find the price predictions for 2019, 2020, 2021, 2022, 2023, 2024.
|Date||Opening price||Closing price||Minimum price||Maximum price||Change|
Immune Pharmaceuticals Inc Stock Price Forecast for 2019
|December 2019||0.0272||5.400||0.000862||12.800||99.5 % ▲|
Immune Pharmaceuticals Inc Stock Price Forecast for 2020
|January 2020||4.050||25.174||1.573||68.863||83.91 % ▲|
|February 2020||70.933||2.668||0.641||70.933||-2558.52 %▼|
|March 2020||2.001||4.392||0.475||34.124||54.44 % ▲|
|April 2020||3.294||5.748||1.017||31.248||42.69 % ▲|
|May 2020||4.311||11.436||0.0113||17.631||62.3 % ▲|
|June 2020||8.577||0.227||0.227||38.064||-3671.03 %▼|
|July 2020||0.171||0.000030||0.00003046||0.171||-559865.46 %▼|
|August 2020||5.376||0.258||0.258||21.786||-1986.5 %▼|
|September 2020||0.193||0.319||0.01088||46.594||39.36 % ▲|
|October 2020||0.239||13.808||0.239||47.557||98.27 % ▲|
|November 2020||10.356||0.00425||0.00425||10.356||-243379.36 %▼|
|December 2020||0.00319||0.000001||0.000000570||0.00319||-559866.93 %▼|
Immune Pharmaceuticals Inc Stock Price Forecast for 2021
|January 2021||0.000001||29.808||0.000001||56.810||100 % ▲|
|February 2021||7.383||0.288||0.288||44.509||-2463.04 %▼|
|March 2021||0.216||5.968||0.00912||18.862||96.38 % ▲|
|April 2021||4.476||1.689||1.689||16.971||-164.99 %▼|
|May 2021||4.336||0.000774||0.000774||4.336||-559866.48 %▼|
|June 2021||0.000581||0.143||0.000245||25.429||99.59 % ▲|
|July 2021||0.1075||0.000019||0.0000192||0.1075||-559863.75 %▼|
|August 2021||0.000014||0.0343||0.00000342||5.410||99.96 % ▲|
|September 2021||0.0257||1.547||0.000258||29.594||98.34 % ▲|
|October 2021||1.160||0.3089||0.3089||33.419||-275.54 %▼|
|November 2021||0.232||0.000055||0.0000552||0.232||-419875.71 %▼|
|December 2021||0.000041||0.000001||0.000001||0.0000414||-559866.49 %▼|
Immune Pharmaceuticals Inc Stock Price Forecast for 2022
|January 2022||0.000001||11.676||0.000001||42.097||100 % ▲|
|February 2022||8.757||0.1083||0.1083||32.684||-7984.49 %▼|
|March 2022||0.0812||0.792||0.0000815||3.336||89.74 % ▲|
|April 2022||0.594||0.000826||0.000826||2.600||-71824.2 %▼|
|May 2022||0.000619||0.000001||0.000000111||0.000619||-559867.62 %▼|
|June 2022||0.000001||0.0492||0.000001||11.644||100 % ▲|
|July 2022||0.0369||0.000007||0.00000659||0.0369||-559867 %▼|
|August 2022||0.000005||0.000001||0.000001||0.00000495||-559866.71 %▼|
|September 2022||0.000001||2.154||0.000001||12.100||100 % ▲|
|October 2022||18.818||0.0145||0.0145||18.818||-129686.68 %▼|
|November 2022||0.01087||0.000003||0.00000259||0.01087||-419872.27 %▼|
|December 2022||0.000002||0.000001||0.000001||0.00000194||-559865.4 %▼|
Immune Pharmaceuticals Inc Stock Price Forecast for 2023
|January 2023||0.000001||0.414||0.000001||26.785||100 % ▲|
|February 2023||0.310||0.000236||0.000236||20.445||-131225.32 %▼|
|March 2023||0.000177||0.000001||0.000001||0.000177||-559867.64 %▼|
|April 2023||0.000001||0.000001||0.000001||0.000001||-419875.01 %▼|
|May 2023||0.000001||0.000001||0.000001||0.000001||-559865.75 %▼|
|June 2023||0.000001||0.000001||0.000001||0.000001||-419875.44 %▼|
|July 2023||0.000001||0.000001||0.000001||0.000001||-559867.96 %▼|
|August 2023||0.000001||0.000001||0.000001||0.000001||-559869.48 %▼|
|September 2023||0.000001||3.716||0.000001||3.716||100 % ▲|
|October 2023||2.787||0.000498||0.000498||2.787||-559865.92 %▼|
|November 2023||0.000373||0.000001||0.000001||0.000373||-419874.64 %▼|
|December 2023||0.000001||0.000001||0.000001||0.000001||-559866.73 %▼|
Immune Pharmaceuticals Inc Stock Price Forecast for 2024
|January 2024||0.000001||3.442||0.000001||10.880||100 % ▲|
|February 2024||2.582||0.327||0.327||7.737||-690.12 %▼|